Licensing Opportunity for Patented Home Drug Testing System

A patented, laboratory-based home drug testing system with prior commercial success is available for strategic licensing. The product previously generated more than $2.58 million in revenue and is positioned to address growing demand in the consumer diagnostics market amid rising drug use and overdose concerns, including fentanyl exposure.

The offering is suited for toxicology, medical, or clinical laboratories seeking a plug-and-play revenue opportunity with existing inventory available for near-immediate commercialization. Qualified laboratory partners should be able to scale testing capacity quickly to support projected market demand in the US consumer diagnostics sector.